Evolent Health, Inc. - Class A Common Stock (EVH)

Historical Holders from Q2 2015 to Q3 2025

Symbol
EVH on NYSE
Type / Class
Equity / Class A Common Stock
Shares outstanding
112M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
136M
Holdings value
$1.15B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
236
Number of buys
119
Number of sells
-113
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evolent Health, Inc. - Class A Common Stock (EVH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CADIAN CAPITAL MANAGEMENT, LP 9.3% $106M 10.8M Cadian Capital Management, LP 31 Mar 2025
FMR LLC 8% +40% $79.7M $23.6M 9.42M +42.2% FMR LLC 30 Sep 2025
MORGAN STANLEY 7% $91.8M 8.21M Morgan Stanley 30 Jun 2025
EVENTIDE ASSET MANAGEMENT, LLC 5.4% +47.5% $53.2M $18.7M 6.29M +54% Eventide Asset Management, LLC 30 Sep 2025
Boehler Adam 5.21% $49.2M 5.82M Rubicon OP GP II LP 13 Nov 2025
RA CAPITAL MANAGEMENT, L.P. 3.1% $35.2M 3.58M RA Capital Management, L.P. 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 0.4% -95.6% $5.02M -$113M 443K -95.8% Wellington Management Group LLP 30 Jun 2025

Institutional Holders of Evolent Health, Inc. - Class A Common Stock (EVH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 136M $1.15B +$12.3M $8.46 236
2025 Q2 132M $1.48B +$78.5M $11.26 218
2025 Q1 126M $1.19B +$20.1M $9.47 222
2024 Q4 122M $1.38B -$248M $11.25 237
2024 Q3 129M $3.65B +$37M $28.28 255
2024 Q2 130M $2.48B +$40.2M $19.12 239
2024 Q1 126M $4.13B -$4.76M $32.79 247
2023 Q4 126M $4.18B +$156M $33.03 232
2023 Q3 122M $3.34B +$125M $27.23 201
2023 Q2 118M $3.55B +$169M $30.30 216
2023 Q1 112M $3.62B +$350M $32.45 237
2022 Q4 101M $2.85B +$147M $28.08 229
2022 Q3 95.5M $3.43B +$215M $35.93 243
2022 Q2 89.7M $2.76B +$99.2M $30.71 207
2022 Q1 86.5M $2.79B +$66.7M $32.30 208
2021 Q4 84.7M $2.34B -$26.2M $27.67 200
2021 Q3 85.6M $2.65B +$83.2M $31.00 205
2021 Q2 83M $1.75B +$24.1M $21.12 175
2021 Q1 82M $1.66B +$54.5M $20.20 163
2020 Q4 81.5M $1.31B +$30.5M $16.03 153
2020 Q3 80M $997M +$91.9M $12.41 147
2020 Q2 73.4M $522M -$8.51M $7.12 127
2020 Q1 76.3M $412M -$45.7M $5.43 144
2019 Q4 84.4M $764M +$19.5M $9.05 160
2019 Q3 83.2M $598M +$36.4M $7.19 164
2019 Q2 79.6M $632M -$65.4M $7.95 176
2019 Q1 80.1M $1.01B -$87.3M $12.58 181
2018 Q4 84.3M $1.68B -$4.94M $19.95 179
2018 Q3 83.5M $2.37B +$83.2M $28.40 184
2018 Q2 81.3M $1.71B +$62.5M $21.05 175
2018 Q1 79.3M $1.13B +$51.2M $14.25 145
2017 Q4 77.2M $950M -$27.8M $12.30 151
2017 Q3 73.8M $1.32B +$165M $17.80 161
2017 Q2 62M $1.57B +$517M $25.35 163
2017 Q1 41.6M $921M +$289M $22.30 131
2016 Q4 29.4M $435M -$1.46M $14.80 116
2016 Q3 27.3M $673M +$205M $24.62 109
2016 Q2 18M $345M +$34.8M $19.20 77
2016 Q1 16.5M $174M +$3.04M $10.56 69
2015 Q4 16.1M $195M +$1.69M $12.11 67
2015 Q3 15.8M $252M +$9.52M $15.96 69
2015 Q2 14.8M $288M +$288M $19.50 62